Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PACBPACB
Showing 8 of 31 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PACIFIC BIOSCIENCES CALIF IN

CITADEL ADVISORS LLC holds 2.8M shares of PACB (PACIFIC BIOSCIENCES CALIF IN), worth $4.8M as of 2026-Q2. The position was increased (+80.6% shares). PACB represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$4.8M

Current Shares

2.8M

Total Value Change

+$4.8M

Total Shares Change

+2.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.8M
+80.6%
$4.8M0.0%$1.68
41
2026-Q1
Decreased
1.6M
-50.2%
$2.1M0.0%$1.52
0
2025-Q4
Increased
3.2M
+26.7%
$5.9M0.0%$1.73
34
2025-Q3
New
2.5M
-
$3.2M0.0%$1.25
37
2025-Q2
Exited
0
-100.0%
$00.0%$1.29
0
2025-Q1
Decreased
22
-100.0%
$260.0%$1.14
0
2024-Q4
Increased
360,981
+16.4Kx
$660,5950.0%$1.79
40
2024-Q3
Decreased
22
-100.0%
$370.0%$1.75
0

Other major holders of PACB: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used